We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study to Look at the Combination of Chemotherapy, Trastuzumab and RAD001 in HER2 Positive Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01163929
Recruitment Status : Withdrawn (Study closed by Protocol Review Monitoring Committee because of lack of accrual)
First Posted : July 16, 2010
Last Update Posted : October 24, 2012
Sponsor:
Collaborator:
Novartis
Information provided by (Responsible Party):
University of Kansas Medical Center ( University of Kansas )

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Primary Completion Date : March 2012
  Study Completion Date : March 2012